JP2021534084A5 - - Google Patents
Info
- Publication number
- JP2021534084A5 JP2021534084A5 JP2021505646A JP2021505646A JP2021534084A5 JP 2021534084 A5 JP2021534084 A5 JP 2021534084A5 JP 2021505646 A JP2021505646 A JP 2021505646A JP 2021505646 A JP2021505646 A JP 2021505646A JP 2021534084 A5 JP2021534084 A5 JP 2021534084A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- optionally
- substituted
- alkyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862715122P | 2018-08-06 | 2018-08-06 | |
| US62/715,122 | 2018-08-06 | ||
| US201862715687P | 2018-08-07 | 2018-08-07 | |
| US62/715,687 | 2018-08-07 | ||
| US201962803332P | 2019-02-08 | 2019-02-08 | |
| US62/803,332 | 2019-02-08 | ||
| PCT/US2019/045259 WO2020033377A1 (en) | 2018-08-06 | 2019-08-06 | Histone demethylase 5 inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021534084A JP2021534084A (ja) | 2021-12-09 |
| JP2021534084A5 true JP2021534084A5 (enExample) | 2022-08-15 |
Family
ID=69414411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021505646A Pending JP2021534084A (ja) | 2018-08-06 | 2019-08-06 | ヒストンデメチラーゼ５阻害剤およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230382865A1 (enExample) |
| EP (1) | EP3833347A4 (enExample) |
| JP (1) | JP2021534084A (enExample) |
| AU (1) | AU2019318046B2 (enExample) |
| CA (1) | CA3106548A1 (enExample) |
| WO (1) | WO2020033377A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11232861B1 (en) | 2021-06-18 | 2022-01-25 | Argos Health Inc. | Systems and methods for displaying predetermined information for clinical use |
| WO2024233765A1 (en) * | 2023-05-09 | 2024-11-14 | Ohio State Innovation Foundation | Therapeutic approach to block terminal exhaustion of t cells and synergize the efficacy of t cell immunotherapies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9408577D0 (en) * | 1994-04-29 | 1994-06-22 | Fujisawa Pharmaceutical Co | New compound |
| MXPA06003951A (es) * | 2003-10-07 | 2006-06-27 | Renovis Inc | Derivados de amida como ligandos del canal de ion y composiciones farmaceuticas y sus metodos de uso. |
| WO2012162291A1 (en) * | 2011-05-24 | 2012-11-29 | The Wistar Institute | Compositions and methods for modulating the activity of epstein-barr nuclear antigen 1 |
| DK2903968T3 (en) * | 2012-10-02 | 2017-01-30 | Gilead Sciences Inc | INHIBITORS OF HISTON DEMETHYLASES |
| PE20151667A1 (es) * | 2013-02-27 | 2015-11-27 | Epitherapeutics Aps | Inhibidores de histona desmetilasas |
| WO2015120320A1 (en) * | 2014-02-06 | 2015-08-13 | Rutgers, The State University Of New Jersey | Antibacterial agents: n(alpha)-aroyl-n-aryl-phenylalaninamides |
| CA2943824A1 (en) * | 2014-03-31 | 2015-10-08 | Gilead Sciences, Inc. | Inhibitors of histone demethylases |
| SG11201701182VA (en) * | 2014-08-27 | 2017-03-30 | Gilead Sciences Inc | Compounds and methods for inhibiting histone demethylases |
| CN105837575B (zh) * | 2015-01-13 | 2019-01-15 | 四川大学 | 3-乙炔基吡唑并嘧啶衍生物及其制备方法和用途 |
-
2019
- 2019-08-06 AU AU2019318046A patent/AU2019318046B2/en active Active
- 2019-08-06 JP JP2021505646A patent/JP2021534084A/ja active Pending
- 2019-08-06 EP EP19848392.7A patent/EP3833347A4/en active Pending
- 2019-08-06 CA CA3106548A patent/CA3106548A1/en active Pending
- 2019-08-06 US US17/265,139 patent/US20230382865A1/en active Pending
- 2019-08-06 WO PCT/US2019/045259 patent/WO2020033377A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023508982A5 (enExample) | ||
| JP2023530231A5 (enExample) | ||
| JP2019527682A5 (enExample) | ||
| JP2022529700A5 (enExample) | ||
| IL268030B2 (en) | Bicyclics as allosteric shp2 inhibitors | |
| JP2020509022A5 (enExample) | ||
| JP2017502006A5 (enExample) | ||
| JP2017537940A5 (enExample) | ||
| JP2022544714A5 (enExample) | ||
| JP2019094345A5 (enExample) | ||
| JP2019524883A5 (enExample) | ||
| JP2020517616A5 (enExample) | ||
| JP2019518766A5 (enExample) | ||
| JP2016510323A5 (enExample) | ||
| JP2010539095A5 (enExample) | ||
| JP2017504595A5 (enExample) | ||
| JP2020535165A5 (enExample) | ||
| JP2013502441A5 (enExample) | ||
| JP2015504076A5 (enExample) | ||
| WO2019012172A1 (es) | Nuevos derivados heteroaryl amida como inhibidores selectivos de histona deacetilasa 1 y 2 (hdac1/2) | |
| JP2010524899A5 (enExample) | ||
| JP2020143129A5 (enExample) | ||
| JP2022548250A5 (enExample) | ||
| JP2022511477A5 (enExample) | ||
| JP2014520108A5 (enExample) |